Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 15, 2015 (11 years ago)

Trimix (A;ph,pa)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Trimix (A;PH,PA) (N), injectable, 160 UG-1.2 mg-9.6/ mg/mL, 2 mL vial, Rx only, compounded by Montana Compounding Pharmacy, Missoula, MT.

Recalling firm
Montana Compounding Pharmacy
Origin
MT, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1125-2015 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Montana Compounding Pharmacy

All 2015 recalls
Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1128-2015
Class II · Moderate risk

Trimix (A;ph,pa)

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1124-2015

Other sterility / contamination recalls from 2015

All sterility / contamination recalls